Stay updated on Liraglutide 3.0 Impact on Body Fat Distribution Clinical Trial
Sign up to get notified when there's something new on the Liraglutide 3.0 Impact on Body Fat Distribution Clinical Trial page.

Latest updates to the Liraglutide 3.0 Impact on Body Fat Distribution Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedA dedicated Locations section with a Texas site was added, replacing the former Texas Locations entry. The HHS Vulnerability Disclosure link was removed and the page revision updated to v3.3.3.SummaryDifference0.2%

- Check24 days agoNo Change Detected
- Check45 days agoChange DetectedPublications section updated to state that PubMed-sourced publications are automatically filled and to note revision v3.3.2, replacing the previous wording about PubMed as the source and revision v3.2.0.SummaryDifference0.1%

- Check52 days agoChange DetectedNotice about the government funding operating status banner was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check67 days agoChange DetectedNo additions or deletions detected on the Study Details page. The content appears unchanged between the two screenshots.SummaryDifference0.4%

- Check95 days agoChange Detected- Added a government operating-status notice and links, clarifying NIH Clinical Center operations and where to check updates. - Updated version from v3.1.0 to v3.2.0.SummaryDifference2%

- Check102 days agoChange DetectedReplaces/phases out pharmaceutical-solution categories with broader chemical categories and updates the version to v3.1.0; several prior solution-related terms are removed.SummaryDifference0.5%

Stay in the know with updates to Liraglutide 3.0 Impact on Body Fat Distribution Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Liraglutide 3.0 Impact on Body Fat Distribution Clinical Trial page.